Clinical Trials
5 trialsNCT01526694 2018-07-03
Phase II Trial Designed to Determine Efficacy and Safety of Bendamustine+Dexamethasone+Thalidomide in R/R MM
Azienda Ospedaliera di Bolzano
Phase 2 Completed
NCT00652041 2011-09-19
TaCyDexVMP7
PETHEMA Foundation
Phase 4 Completed
NCT00602511 2011-02-09
Thalidomide Versus Bortezomib in Melphalan Refractory Myeloma
Nordic Myeloma Study Group
Phase 3 Completed
NCT00083681 2010-07-02
DCEP in Combination With Thalidomide as Salvage Therapy for Post Transplantation Relapse
University of Arkansas
Phase 2 Completed
NCT00083694 2010-07-02
Thalidomide Anti-Angiogenesis Therapy of Relapsed or Refractory Leukemia
University of Arkansas
Phase 2 Completed